Alzheimer's agitation drug safety trial halted early
NCT ID NCT06736509
First seen Feb 23, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This study tested the long-term safety of AXS-05, an experimental drug for agitation in people with Alzheimer's disease. It included 139 adults who had already completed earlier studies. The trial was terminated early, and its main goal was to track side effects, not to cure Alzheimer's or stop its progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Site
Peoria, Arizona, 85381, United States
-
Clinical Research Site
Walnut Creek, California, 94596, United States
-
Clinical Research Site
Bonita Springs, Florida, 34134, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Greenacres City, Florida, 33467, United States
-
Clinical Research Site
Hialeah, Florida, 33012, United States
-
Clinical Research Site
Miami, Florida, 33126, United States
-
Clinical Research Site
Miami, Florida, 33145, United States
-
Clinical Research Site
Miami, Florida, 33155, United States
-
Clinical Research Site
Miami, Florida, 33165, United States
-
Clinical Research Site
Miami, Florida, 33173, United States
-
Clinical Research Site
Miami Gardens, Florida, 33014, United States
-
Clinical Research Site
Miami Lakes, Florida, 33014, United States
-
Clinical Research Site
Pembroke Pines, Florida, 33025, United States
-
Clinical Research Site
Tampa, Florida, 33614, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Braintree, Massachusetts, 02184, United States
-
Clinical Research Site
Brooklyn, New York, 11229, United States
-
Clinical Research Site
Charlotte, North Carolina, 28211, United States
-
Clinical Research Site
Mesquite, Texas, 75149, United States
-
Clinical Research Site
Arlington, Virginia, 22205, United States
-
Clinical Research Site
San Juan, 00918, Puerto Rico
Conditions
Explore the condition pages connected to this study.